Sotatercept Endorsed for PAH by ICER
Drug's novel mechanism of action raises hopes of disease-modifying activity, but long-term cost-effectiveness rests on improvement in functional status.
Source: medscape.com
Page 23 - Adverse Effects News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Adverse Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Adverse Effects Today - Breaking & Trending Today
Most Stop Taking Weight Loss Drugs Within 1 Year
Continuation rates are higher with the new, more effective drugs, but even among those patients, more than half discontinue within a year.
Source: medscape.com
The Prospect of a Medication to Treat OSA Is Getting Closer
A recent study assessed a combination of aroxybutynin, which has an antimuscarinic effect, and atomoxetine, which has a noradrenergic effect, in treating OSA.
Source: medscape.com
Paranovus Entertainment Technology : NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS - Form 6-K -December 05, 2023 at 05:28 pm EST
NOTICE OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN THAT the extraordinary general meeting of holders of Class B ordinary shares, par value $0.01...
Source: marketscreener.com
Pfizer Drops Twice-Daily Version of Obesity Pill Over Side Effects
Pfizer said on Friday it would not advance a twice-daily version of oral weight-loss drug danuglipron into late-stage studies after most patients dropped out of its midstage trial with high rates of side effects such as nausea and vomiting.
Source: medscape.com